Literature DB >> 32636526

Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines.

Takashi Hisamatsu1,2, Hiroyoshi Segawa3, Aya Kadota3,4, Takayoshi Ohkubo5, Hisatomi Arima6, Katsuyuki Miura3,4.   

Abstract

From the national surveys of Japan over a 55-year period (1961-2016), a steady decrease was observed in systolic blood pressure (BP) levels among all age groups of men and women, but not in diastolic BP levels-particularly among men. Hypertension prevalence remains high: over 60% of men aged ≥50 years and women aged ≥60 years had hypertension in 2016. However, the control rates of hypertension have continuously improved over a 36-year period, and were ~40% in 2016. Nonetheless, the over 50% prevalence of uncontrolled hypertension is a major risk factor for future cardiovascular diseases. Of the estimated 43 million hypertensives in Japan, most (31 million, 72%) were under poor control. According to new Japanese hypertension guidelines (JSH 2019), there will be only a small increase (2.2 million, 2.1 percentage points) in adults who are recommended for antihypertensive medication compared with 2014 guidelines. However, an additional 5.3 million (22.1 percentage points) adults taking antihypertensive medication would have a BP above the target defined by JSH 2019. The number of hypertensives with poor control was targeted to decrease by 7 million-from 31 million in 2017 to 24 million in 2028-when the followings are achieved: (1) the prevalence of hypertension decreases by 5 percentage points; (2) the treatment rate of hypertension among hypertensives increases by 10 percentage points; and (3) the control rate of hypertension, defined as BP <140/90 mmHg, among individuals taking antihypertensive medication increases by 10 percentage points. Both high-risk and population strategies to manage and prevent hypertension deserve greater priority.

Entities:  

Keywords:  Blood pressure; Epidemiology; Hypertension; Japan; Prevalence

Year:  2020        PMID: 32636526     DOI: 10.1038/s41440-020-0508-z

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

1.  A Mobile Health-Based Disease Management Program Improves Blood Pressure in People With Multiple Lifestyle-Related Diseases at Risk of Developing Vascular Disease - A Retrospective Observational Study.

Authors:  Masashi Kanai; Takuya Toda; Kojiro Yamamoto; Marina Akimoto; Yuta Hagiwara
Journal:  Circ Rep       Date:  2022-05-31

2.  Latest hypertension research to inform clinical practice in Asia.

Authors:  Kazuomi Kario; Masaki Mogi; Satoshi Hoshide
Journal:  Hypertens Res       Date:  2022-04-05       Impact factor: 5.528

3.  2022 Malaysian Working Group Consensus Statement on Renal Denervation for management of arterial hypertension.

Authors:  Yook Chin Chia; Wan Azman Wan Ahmad; Alan Yean Yip Fong; Azhari Rosman; Abdul Rashid Abdul Rahman; Gim Hooi Choo; Soo Kun Lim; Mohammad Zawawi Abu Bakar; Tiong Kiam Ong
Journal:  Hypertens Res       Date:  2022-06-01       Impact factor: 5.528

4.  Hypertension, cardiovascular disease, and nocturia: a systematic review of the pathophysiological mechanisms.

Authors:  Mitsuru Ohishi; Takuro Kubozono; Koji Higuchi; Yuichi Akasaki
Journal:  Hypertens Res       Date:  2021-03-03       Impact factor: 3.872

5.  Development of a risk prediction model for incident hypertension in Japanese individuals: the Hisayama Study.

Authors:  Emi Oishi; Jun Hata; Takanori Honda; Satoko Sakata; Sanmei Chen; Yoichiro Hirakawa; Daigo Yoshida; Mao Shibata; Tomoyuki Ohara; Yoshihiko Furuta; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Hypertens Res       Date:  2021-05-31       Impact factor: 3.872

Review 6.  Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Saulat Siddique; Yuda Turana; Yan Li; Chen-Huan Chen; Jennifer Nailes; Minh Van Huynh; Peera Buranakitjaroen; Hao-Min Cheng; Takeshi Fujiwara; Satoshi Hoshide; Michiaki Nagai; Sungha Park; Jinho Shin; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-02-16       Impact factor: 3.738

7.  Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single-Dose Crossover Studies in Healthy Japanese Men.

Authors:  Akifumi Kurata; Takashi Eto; Junko Tsutsumi; Yoshiyuki Igawa; Yasuhiro Nishikawa; Hitoshi Ishizuka
Journal:  Clin Pharmacol Drug Dev       Date:  2022-03-21

8.  Hypertensive Disorders during Pregnancy (HDP), Maternal Characteristics, and Birth Outcomes among Japanese Women: A Hokkaido Study.

Authors:  Kritika Poudel; Sumitaka Kobayashi; Chihiro Miyashita; Atsuko Ikeda-Araki; Naomi Tamura; Yu Ait Bamai; Sachiko Itoh; Keiko Yamazaki; Hideyuki Masuda; Mariko Itoh; Kumiko Ito; Reiko Kishi
Journal:  Int J Environ Res Public Health       Date:  2021-03-24       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.